Skip to main content

Drug Interactions between betibeglogene autotemcel and Emtriva

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

emtricitabine betibeglogene autotemcel

Applies to: Emtriva (emtricitabine) and betibeglogene autotemcel

Emtricitabine may interfere with the process used to make betibeglogene autotemcel from your own blood cells. The makers of betibeglogene autotemcel recommend that emtricitabine be stopped before your blood stem cells are collected. You should speak with your doctor to ensure that emtricitabine is stopped at the appropriate time. Betibeglogene autotemcel may also interfere with the results of certain types of laboratory tests. Be sure to speak with the laboratory or your healthcare provider if you need to be screened for certain types of viruses, like human immunodeficiency virus (HIV), to ensure that treatment with betibeglogene autotemcel does not interfere with the test. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer